Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.350 | The Development of an Intelligent System for Real-time Automated Anatomical Recognition System During Endoscopic Ultrasound | Prof. CHAN Shannon |
| 2025.324 | Establishment of Hong Kong Diabesity Register and a 3-year Randomized Clinical Trial for the Investigation of the Effectiveness of a Multicomponent Integrated Care Program in Chinese with Diabesity | Prof. KONG Alice Pik Shan |
| 2025.319 | App-assisted implementation of evidence-based management of acute intracerebral haemorrhage |
Dr. IP Bonaventure Yiu Ming 葉耀明 |
| 2025.356 | Development for AI-Powered Nasal Cavity Reconstruction | Prof. TONG Michael C.F. |
| 2025.351 | Long-term effects and healthcare costs of extreme heat on cardiovascular complications in Chinese patients with type 2 diabetes | Dr. LAU Siu Him |
| 2025.316 | Can biologic DMARD use retard syndesmophytes and facet joint arthritis progression and resolve axial inflammatory in psoriatic arthritis? A prospective follow up study using low-dose computed tomography and magnetic resonance imaging | Prof. TAM Lai Shan |
| 2025.352 | Review of hip fracture patients with history of fragility fracture | Dr. FUNG Kwun Ping |
| 2025.358 | Investigating the Predictive Power of Coronary Plaque for Major Adverse Cardiovascular Events (MACE) in Psoriatic Arthritis: A 10-year Retrospective Study | Prof. TAM Lai Shan |
| 2025.335 | Butyrate and Taurine to reduce chronic postsurgical pain in adult cardiac surgical patients: a Bayesian Optimized double-blinded randomized controlled trial | Dr. WONG Man Kin |
| 2025.331 | Effectiveness of a Game-based educational workshop on Hong Kong students’ change in self-efficacy, awareness, and attitudes to drug abuse | Prof. LI William Ho Cheung |
| 2025.353 | An in-vitro study to examine the activity of Avibactam-aztreonam against Carbapenem resistant gram-negative bacilli in a tertiary referral laboratory in Hong Kong | Dr. LAI Christopher Koon Chi |
| 2025.330 | Effectiveness of Virtual Reality-enhanced Interventions on Preoperative Anxiety in Adults Undergoing Elective Surgery: A 3-arm randomised controlled trial (VIPA trial) | Mr. CHAN Sin Lun |
| 2025.359 | A two-part phase 1 open-label safety and pharmacokinetic study of intravenous RC220 in combination with doxorubicin in adult patients with solid tumours | Dr. LOONG Herbert Ho Fung |
| 2025.304 | Voice Link 2.0 AI Speech Recognition Investigation | Dr. FONG Raymond |
| 2025.303 | Voice Link 2.0 AI Speech Recognition Investigation | Dr. CHAN Edwin Ho Yin |
| 2025.355 | Retrospective Study Protocol – Data collection for AutoTV and AutoView |
Prof. LEE Alex Pui Wai 李沛威 |
| 2025.322 | Development and validation of a new scale to assess sexual problems in people with prostate cancer and to design an electronic patient-reported outcome measure for this population (ePROM-SexPCare) | Prof. NG Chi Fai |
| 2025.329 | The effects of theory-guided multimodal educational (TIME) programme on the faecal occult blood test (FOBT) uptake rates among adults at average-risk of colorectal cancer: A randomized controlled trial | Ms. KWAN Siu Kuen |
| 2025.310 | Systemic absorption of oral vancomycin: prevalence, risk factors, and clinical implications |
Prof. SZETO Cheuk Chun Cheuk Chun Szeto |
| 2025.315 | The Chinese University of Hong Kong Myasthenia Gravis Registry (CUHKMGR) | Dr. CHOI Joseph Chun Ho |
| 2025.311 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2025.305 | Retrospective Review on the Management of Diabetic Ketoacidosis in the Intensive Care Unit | Dr. HO Lap Tin |
| 2025.323 | Pilot Study on Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer | Prof. TEOH Jeremy Yuen Chun |
| 2025.309 | A portable “sample to answer” microfluidic system for rapid detection of bacterial pathogens using nucleic acid analysis | Prof. LING Lowell |
| 2025.314 | Psychological Distress and its Predictive Factors among Parents of Sick Children | Dr. HO Long Kwan |
| 2025.317 | Effectiveness of a Mindfulness-Oriented Respiratory Distress Symptom Intervention for Patients with Lung Cancer and Its Association with Brain Activity Changes | Dr. LOONG Herbert Ho Fung |
| 2025.343 | Development for AI-Powered Retrograde Intrarenal Surgery | Prof. NG Chi Fai |
| 2025.308 | A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in combination with Durvalumab, Carboplatin and Etoposide versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312) | Dr. LOONG Herbert Ho Fung |
| 2025.307 | ASKHER2-China: Perceptions, attitudes, and behaviors towards the risk of disease recurrence among women with early-stage HER2+ breast cancer in mainland China and Hong Kong | Prof. YEO Winnie |
| 2025.328 | Effect of A Remote Counselling Programme on Screening Uptake in First-Degree Relatives of Colorectal Cancer Patients: A Randomised Controlled Trial |
Ms DONG Bei 董贝 |
| 2025.306 | A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma | Prof. CHAN Stephen Lam |
| 2025.318 | A Phase III, randomised, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronchiectasis (The AIRTIVITY® Study) | Prof. HUI David Shu Cheong |
| 2025.347 | Impact of intrinsic capacity on the patient-reported and clinical outcomes of geriatric patients | Dr. LEE Jenny Shun Wah |
| 2025.362 | Phase I-II study of JS207 a bispecific antibody against PD1-VEGF in the treatment of recurrent/metastatic nasopharyngeal carcinoma | Prof. MA Brigette Buig Yue |
| 2025.354 | Evaluation of responses generated by ChatGPT and DeepSeek to drug information questions in hospital setting of Hong Kong | Prof. YOU Joyce Hoi Sze |
| 2025.326 | Development of Zinc Transporter ZIP10-Based Targeted Antibody-Drug Conjugates and Mechanism of Anti-Gastric Cancer |
Dr. CHEN Bonan 陳博南 |
| 2025.357 | Reconstruction and application of interactive virtual environments with real-time navigation for training, planning and rehearsal of transcanal endoscopic ear surgery | Dr. CHANG Wai Tsz |
| 2025.341 | Establishment of a Novel Non-Invasive Biomarker Panel in Peripheral Blood Mononuclear Cells for Predicting Immunotherapy Response in Hepatocellular Carcinoma | Prof. LONG Xiaohang |
| 2025.301 | Multicentre retrospective comparative study of early-onset colorectal cancer (EOCRC): Analysis of clinicopathological, familial and prognostic differences according to the geographical location | Dr. LUI Rashid N.S. |
| 2025.366 | A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of VRN110755 in Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) | Dr LI Siu Ching Molly |
| 2025.302 | A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants with EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer whose Disease has Progressed on Prior Osimertinib Treatment (TROPION-Lung15) | Dr. LI Molly Siu Ching |
| 2025.312 | The impact of contemporary neoadjuvant and adjuvant chemotherapy treatment regimens on recurrence and survival in resectable, borderline resectable, locally advanced and metastatic adenocarcinoma arising from IPMN and internal validation of 2023 KYOTO Guidelines: ADENO-IPMN 2 study | Dr. LUI Rashid N.S. |
| 2025.299 | Multimodality biopsychosocial evaluation and non-pharmacological interventions for cognitive function decline in patients with treatment-resistant schizophrenia-spectrum disorders | Dr. WONG Yip Chau |
| 2025.282 | Investigating the Abnormal Neuromotor Development of Scoliosis from Childhood to Adulthood |
Prof. CHEUNG Vincent Chi Kwan Kelvin Lau |
| 2025.281 | A personalized closed-loop neurofeedback training protocol for emotion regulation in adolescents with major depressive disorder |
Dr. WANG Yang Yang WANG |
| 2025.297 | Neurobiological Studies on Entrepreneurs, Investors/Managers, and Scientists | Prof. AU Kevin |
| 2025.271 | A schedule of work to evaluate the effects of ingestion of various combinations of amino acids on glucose metabolism in healthy individuals and people with impaired glucose tolerance | Prof. CHAN Juliana C.N. |
| 2025.284 | A Retrospective Analysis of Risk Factors, Treatments and Outcomes of Cancer-associated Venous Thromboembolism in Chinese Patients | Dr. WONG Raymond Siu Ming |
| 2025.285 | A Deep Learning System for Predicting Myopia Risk and Atropine Treatment Efficacy | Dr. ZHANG Yuzhou |
| 2025.266 | Prevalence and risk factors of Accelerated Biological Aging in Critically ill and Postoperative Patients: a multicenter prevalence study | Prof. HO Kwok Ming |
Page 2 of 267.